Evaluation of CCL5 -403 G>A and CCR5 Δ32 gene polymorphisms in patients with breast cancer.

doi:10.3233/CBM-140411

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Evaluation of CCL5 -403 G>A and CCR5 Δ32 gene polymorphisms in patients with breast cancer.

Cancer biomarkers : section A of Disease markers - 1 Jan 2014

Eskandari-Nasab Ebrahim, Hashemi Mohammad, Ebrahimi Mahboubeh, Amininia Shadi, Bahari Gholamreza, Mashhadi Mohammad-Ali, Taheri Mohsen

Abstract excerpt

BACKGROUND: Recent evidence has demonstrated the implication of CC chemokine ligand 5 (CCL5) and CC chemokine receptor 5 (CCR5) in breast tumor initiation and progression. OBJECTIVE: The purpose of this study was to investigate whether single nucleotide polymorphisms of CCL5 -403 G>A (rs2107538) and CCR5 Δ32 genes are associated with the breast cancer (BC) risk. METHODS: A total of 439 subjects including on 236...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Case-Control Studies

Share to Chemokine CCL5

Share to Genetic Predisposition to Disease

Share to Polymorphism, Single Nucleotide

Share to Risk

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 25171476
DOI: 10.3233/CBM-140411
PMCID: PMC12928332

Genes

CCL5
CCR5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of CCL5 -403 G>A and CCR5 Δ32 gene polymorphisms in patients with breast cancer.PMID 25171476Read ↗

CCL5-403, CCR5-59029, and Delta32 polymorphisms and cancer risk: a meta-analysis based on 20,625 subjects.Semantic proximity Read ↗

The delta32 allele distribution of the CCR5 gene and its relationship with certain cancers in a Turkish population.Semantic proximity Read ↗

Impact of chemokines CCR5∆32, CXCL12G801A, and CXCR2C1208T on bladder cancer susceptibility in north Indian population.Semantic proximity Read ↗

Association between chemokine receptor 5 delta32 polymorphism and susceptibility to cancer: a meta-analysis.Semantic proximity Read ↗

Characterization of lncRNA LINC00520 and functional polymorphisms associated with breast cancer susceptibility in Chinese Han population.Semantic proximity Read ↗

Study of association between rs72703442 and rs55683539 genetic variants in MIR31HG and the risk of breast cancer.Semantic proximity Read ↗

Association between Vascular Endothelial Growth Factor Gene Polymorphisms with Breast Cancer Risk in an Iranian PopulationSemantic proximity Read ↗

The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.Semantic proximity Read ↗

Impact of MIR31HG polymorphisms on risk of breast cancer in Chinese women.Semantic proximity Read ↗

Higher circulating levels of chemokine CXCL10 in patients with breast cancer: Evaluation of the influences of tumor stage and chemokine gene polymorphism.Semantic proximity Read ↗

Association between gene polymorphism of GRK5 and breast cancer risk in Chinese population.Semantic proximity Read ↗

Association study of SNPs in LncRNA CDKN2B-AS1 with breast cancer susceptibility in Chinese Han population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.